Members of the genus Bifidobacterium represent an important bacterial group for promoting health 27 during early life. Previous studies have indicated that bifidobacterial exopolysaccharides (EPS) are 28 involved in host interactions, with purified EPS also suggested to modulate microbe-microbe 29 interactions by acting as a nutrient substrate. To further explore the role of EPS as a potential dietary 30 component, we determined the longitudinal effects of bifidobacterial EPS on microbial communities 31 and metabolite profiles using an infant model colon system. Bifidobacterium breve UCC2003 was 32 utilised as a representative early life bifidobacterial strain, and a corresponding isogenic EPS-deletion 33 mutant (B. breve UCC2003 EPS-). Initial transcriptomics analysis of the EPS mutant vs. parent B. breve 34 UCC2003 strain highlighted differential expression in a discrete number of genes, including the eps 35 biosynthetic cluster, though overall growth dynamics between the two strains were unaffected. Model 36 colon vessels were inoculated with B. breve strains and microbiome dynamics were monitored using 37 metataxonomic (via 16S rRNA sequencing) and metabolomic (via 1 H NMR) approaches. Baseline early 38 life microbiota profiles were similar between vessels, with persistence of B. breve observed between 0-36h. Within the EPS-positive vessel there was a significant shift in microbiome 40 and metabolite profiles until the end of the study (405h); we observed increases of Escherichia and 41
Introduction

55
Members from the genus Bifidobacterium represent one of the dominant bacterial groups in the early 56 life gut microbiota, with high levels associated with improved infant health [1] [2] [3] [4] [5] . Unlike the adult gut 57 microbiome, the infant microbiome is less stable, and dietary change is proposed to lead to severe 58 shifts in the abundance of major bacterial taxa over time [4, 6, 7] . The gut microbiota of breast-fed 59 infants is dominated by Bifidobacterium (approx. 80% of the total community), which represents an 60 important microbial pioneer or founder genus [8, 9] . In contrast, formula-fed infants have a more 61 diverse microbiota and bifidobacteria comprise a smaller proportion (approx. 5-30%) [10] . The 62 introduction of solid food at weaning marks a transition into a more complex microbiome, with a 63 concurrent reduction in Bifidobacterium levels, likely due to the loss of milk as a sole dietary source. 64
Notably, during these phases of significant dietary change, there is a shift in bifidobacterial species 65 and strains, which may link to the wider repertoire of enzymes capable of digesting a more 'adult' diet 66 [3, 5, 6, 11, 12] . 67
Currently, only a small number of studies have explored the mechanisms by which Bifidobacterium 68 species modulate the wider microbiota and/or provide benefits to the host. Several groups have 69 provided data indicating that many Bifidobacterium species and strains produce exopolysaccharides 70 (EPSs), which appear to have a variety of roles in microbe-host and microbe-microbe interactions [13] . 71
Bacterial EPS are polymerised mono-or oligo-saccharides which form a diverse range of homo-or 72 hetero-polysaccharides, that can be linked to the bacterial cell wall or secreted. Analyses of several 73
Bifidobacterium species has revealed the presence of EPS gene clusters [14] , with chemical analysis 74 indicating glucose and galactose as major components, with very low levels of rhamnose also present 75 throughout these structures [15, 16] . To date, most studies have focused on EPS-host interactions 76 including; adhesion to host cells, and modulation of epithelial and immune responses [17] [18] [19] [20] . 77
Microbe-microbe interactions are a key feature of community structuring and are often mediated 78 through cross-feeding of microbial-derived metabolites [21] . Interestingly, bifidobacterial EPS has 79 previously been reported to act as a nutrient source for other bacteria within microbial communities. 80
In two independent studies, Salazar and colleagues found that isolated EPS from human-associated 81
Bifidobacterium species may act as a fermentable substrate for other members of the microbiota in 82 faecal batch cultures (which was species and strain dependent) [22, 23] . More recently, this inter-83 microbial cross-feeding was also shown in vitro, with EPS from Bifidobacterium animalis subsp. lactis 84
and Bifidobacterium longum promoting growth of Bacteroides fragilis, which correlated with 85 increased short-chain fatty acid (SCFA) production [24] . 86 4 Collectively, these studies suggest a potential role for EPS in microbe-microbe interactions, by acting 87 as a substrate within gut microbiota cross-feeding networks. However, the exact role of bifidobacterial 88 EPS in community re-structuring is currently unclear as previous studies supplemented vessels with 89 purified EPS, rather than administrating an EPS-producing Bifidobacterium strain (which would mimic 90 the actual gut environment). Here we explored the effects of B. breve UCC2003 (EPS-positive) and B. 91 breve UCC2003del (EPS-negative) on the microbiota using an infant model colon system. We 92 established differential gene expression and growth characteristics in vitro of each strain, prior to 93 supplementation, and then performed longitudinal microbiota (via 16S rRNA) and metabolomic (via 94 NMR) profiling, which indicated that EPS produced by B. breve UCC2003 can function as a potential 95 dietary substrate that induces remodelling of the early life microbiota. 96
97
Results
98
Surface-associated EPS influences B. breve gene expression 99
Pure bacterial cultures were subjected to transmission electron microscopy to visualise the presence 100 and absence of EPS prior to model colon experiments. Images indicated EPS-positive B. breve UCC2003 101 bacteria had a thicker and differentially stained cell wall (as indicated by arrows, Fig 1a) in contrast to 102 the EPS-negative strain (i.e. B. breve UCC2003del); which is in line with previously published data [17] . 103
Previous work has suggested that bacterial EPS may act as a signaling molecule, and therefore its 104 absence may alter bacterial gene expression [17] . To examine this, we grew B. breve EPS-positive and 105 B. breve EPS-negative in culture until mid-exponential phase and isolated mRNA for transcriptome 106 analysis. Principal component analysis (PCA) showed separation between EPS-positive and EPS-107 negative conditions (45% of variance, Fig S1a) , in addition we found 51 upregulated and 83 108 downregulated genes (comparing EPS-positive to EPS-negative with an absolute log2 fold change ≥1 109 and p adjusted value ≤ 0.05; Fig 1b and Fig 1c) . Annotation of regulated genes indicated high 110 differential expression around the B. breve EPS cluster (Fig 1d; cluster at position ~600,000). The EPS-111 related cluster was the only full gene cluster differently regulated between the two isolates during 112 growth in rich media, suggesting that these strains are highly similar despite the lack of EPS structure 113 on the mutant strain. Using EggNog mapper to functionally classify differentially expressed genes 114 (from EPS+ vs EPS-cultures), the majority of genes were assigned to unknown function (18 genes up-115 regulated in EPS+ and 25 genes upregulated in EPS-, data not shown). In general, we found that the 116 EPS-strain had a greater number of significant genes upregulated in metabolic pathways (including 117 carbohydrate, nucleotide, inorganic ion, lipid and amino acid transport/metabolism) and bacterial cell 118 5 growth (cell wall/membrane/envelope biogenesis and transcription; Fig 1e) . Overall the EPS+ strain 119 had fewer significantly differentially expressed genes, but in contrast to EPS-, EPS+ bacteria had a 120 higher proportion of gene expression related to replication/recombination and repair, energy 121 production and post-translation modification/protein turnover/chaperones and coenzyme transport 122 and metabolism (Fig 1e) . Collectively, this data suggests that the absence of EPS alters gene expression 123 of many metabolic pathways, but importantly it does not influence overall growth kinetics (Fig S1b) . 124
B. breve EPS influences infant microbiome composition over time 125
To determine if bifidobacterial EPS acts as an additional nutrient substance, impacting cross-feeding 126 activities, B. breve strains were inoculated into a complex infant model colon system (as depicted in 127 To offset the variability of microbial community dynamics that occur when stool samples from multiple 131 infants are mixed and grown together in batch culture, all vessels were acclimatised for 10 days to 132 stabilise ecosystems prior to B. breve supplementation at t=0 (Fig S2) . B. breve levels were monitored 133 over time by analysis of species-specific 16S rRNA abundance [25] ; this method indicated that B. breve 134 reads were only detectable at time 0h (following inoculation of each vessel) (Fig S4a and S4b) . 135
Sampling at 6h-36h post-supplementation showed presence of B. breve suggesting short-term 136 colonisation within the infant model colon system. After a full media exchange (approx. 12h) B. breve 137 accounted for approximately half of the total Bifidobacterium relative abundance within the EPS-138 positive vessel, and one-third of the total bifidobacterial abundance in the EPS-negative vessel (Fig 139 S4a and S4b). This is perhaps unsurprising, since it has been previously reported that once stability 140 has been reached in the microbiota, only one-third of individuals are colonized with Bifidobacterium 141 after supplementation [26] . Despite short-term colonisation, overtime microbial diversity in each 142 vessel shifted as indicated by NMDS plots of total taxonomic profiles (Fig 2b and Figure S3a and S3b), 143 with specific changes in microbial composition and abundancy observed in each vessel throughout the 144 experimental period (Fig 3 & S5 , Table S2 & S3). Comparing the wider bacterial genus community 145 profiles of the vessels indicated that both EPS-positive and EPS-negative conditions had similar core 146 microbiomes, therefore we chose to focus our analysis on the top five genera in each condition. All 147 vessels were dominated with a high proportion of (1) Clostridium, (2) Bacteroides and (3) 148
Erysipelatoclostridium across all time points (Fig 3a and 3b) . Within the EPS+ vessel Faecalibacterium 149 was the fourth most abundance genera across all time points; whilst bacteria belonging to the genera 150
Escherichia were the fifth most prevalent at 0-36h, from 48-129h Tyzzerella was fifth, and 151 6 Enterococcus from 144-408h (Figure 3a and Table S2 ). These shift in the top five genera within vessels 152 corresponded to three unique microbial 'phases' (I, II, and III). Notably, presence of EPS (i.e. EPS+ 153 vessel) correlated with different ecosystem structuring (Figure 3b and Table S3 ). Earlier time-points 154 (0-36h) showed similar relative genus abundances when compared to the EPS-vessel; Clostridium, 155
Bacteroides, Erysipelatoclostridium, Faecalibacterium and Escherichia. However, in the second phase 156 from 48-120h, Faecalibacterium relative abundance was increased, with proportions of Clostridioides 157 decreased (starting just before the second phase at 36h). Between 96h-120h, Lachnoclostridium and 158
Tyzzerella had decreased read counts, whereas Escherichia increased. In the last phase, 144h-408h, 159
Clostridium, Bacteroides and Erysipelatoclostridium, Faecalibacterium and Tyzzerella or Escherichia 160 were most abundant, with Enterococcus relative abundance decreased, whereas the number of reads 161 from Tyzzerella increased towards the end. These profiles indicate distinct and major changes in 162 bacterial genera in response to B. breve UCC2003-associated EPS. 163
Using Kendall rank correlation coefficient analysis, we next assessed if the presence of total 164
Bifidobacterium correlated with other bacterial genera (Fig S6) . Overall, we noted that most genera 165 were found to be (weakly) negatively correlated in the EPS+ vs. the EPS-vessel, with a strongly positive 166 co-occurrence of Bifidobacterium with Faecalibacterium in the EPS-vessel (p= 0.033; Fig S6) . To 167 determine putative EPS cross-feeding partners we also analysed for co-occurrences with B. breve (i.e. 168 specific for EPS+/EPS-supplemented strains) we found that, although not significant, there was a trend 169 for more positive correlations with several genus in the EPS+ vessel including Streptococcus and 170
Ruminococcus. In general, we observed fewer positive correlations EPS-B. breve correlations, with the 171 genus Dorea significantly negatively correlated (Fig S6) . Collectively, this might suggest that the 172 presence of EPS is responsible for driving changes in microbiome profiles, likely due to the fact it can 173 function as a potential metabolite for other members in the microbiota. 174
Metabolite profiles shift in response to bifidobacterial EPS. 175
Using 1 H NMR, we next sought to examine if the taxonomic compositional changes observed were also 176 linked to overall metabolic changes. In agreement with the microbiota profiles, both vessels had 177 similar starting metabolite concentrations prior to the introduction of B. breve (Fig S7a) . The most 178 abundant metabolites in each vessel were formate, succinate, ethanol, and bacterial fermentation by-179 product SCFAs: acetate, butyrate and propionate ( Fig. 4a-d ; Table S4 ). Proportions of all SCFAs 180 increased over time independent of the presence/absence of EPS (Fig 4c-d) [27] . We also observed 181 that within the EPS-vessel, the concentration of ethanol increased as time progressed, whilst the EPS+ 182 vessel appeared to have decreasing levels. The abundance of the simple organic compound formate 183 increased in abundance until 120h within the EPS+ vessel, then dropped in the third phase (144-406h) 184 7 but remained stable in the EPS-vessel. We observed that the sugar compound succinate decreased 185 with time in the EPS-vessel, whilst levels were unchanged in the EPS+ system. Taken together these 186 results further suggest that addition of bacteria with an EPS structure alters bacterial function and 187 metabolic output. 188
Direct comparison of metabolic and microbiota analysis using the Spearman correlation analysis 189 identified changes in bacterial profiles that could be linked to EPS-mediated metabolic changes ( Fig  190   2a, 5 & S7b) . Overall, we noted more significant associations in the EPS+ vessel, and therefore chose 191 to focus on the most abundant metabolites with the top 10 bacterial genera across the experimental 192 period. The strongest positive correlations (i.e. both genus and metabolite increasing; p<0.001) were 193 observed in the EPS+ vessel between Bifidobacterium and ethanol; Tyzzerella, Escherichia, 194 Clostridium, Agathobacter and formate; Enterococcus, Bacteroides and propionate and, Escherichia 195 and succinate (Fig 5; which is similar to that proposed for UCC2003 EPS structure (includes glucose, galactose and/or the 234 N-acetylated versions of these two sugars in different ratios or composition) [13, [15] [16] [17] . The large 235 molecular weight and structure of these EPS may prevent host-associated digestion, allowing them to 236 act as prebiotics within the colon (similar to inulin and fructooligosaccharide) [19, 29, 30] . Interestingly 237 we found that Escherichia increased over time and was highly correlated (positively) with 238
Bifidobacterium in the EPS+ vessel from 0-36h (when B. breve could be detected). Escherichia is known 239 to encode β-galactosidase genes that may allow degradation of the sugars present in EPS polymers 240 [31, 32] ; potentially correlating with the increases in metabolites such as ethanol, propionate and 241 formate also during this growth phase [33, 34] . The infant-gut associated bacteria Tyzzerella [3], was 242 also dominant in the EPS+ vessel (at 48h) and may therefore use EPS as a key nutritional supplement. 243
Although little is known regarding the metabolism of members the Tyzzerella genus, many other 244 members of the family Lachnospiraceae possess glycoside hydrolases used for the metabolism and 245 transport of oligosaccharides into the cell [35] . Furthermore, another member of the Lachnospiraceae 246 family, Ruminococcus, degrades intestinal mucins (similar in structure to EPS) liberating metabolites 247 for other members of the microbiota to consume [36] . Thus, the positive correlation of Tyzzerella with 248 formate in the EPS+ vessels suggests that, similar to other members in the Lachnospiraceae family, 249
Moreover, we observed several other strong negative correlations between different genus (e.g. 251 Dorea) and B. breve UCC2003, which also suggests antagonistic networks may be EPS-dependent, but 252 further studies are required to understand the mechanisms promoting these inverse relationships. 253
As highlighted above, the infant microbiota represents a dynamic ecosystem, with complex feeding 254 networks at play, which may also be acting in response to EPS metabolism. We noted several potential 255 wider cross-feeding networks (rather than direct EPS digestion interactions) during different growth 256 phases. Specifically, utilisation of B. breve EPS by primary degraders e.g. Escherichia producing N-257 acetylaspartate may also facilitate growth of secondary degraders such as weaning-associated 258
Faecalibacterium, important butyrate producers, as these metabolites correlate respectively with the 259 two genera [38] [39] [40] [41] . Another possible interaction is via predicted production of formate by Tyzzerella, 260 that may be metabolised by Faecalibacterium, as has been described in an in silico biofilm model [42] 261 (Fig S8) . Delineating intricate and complex cross-feeding relationships is difficult and cannot be 262 predicted from non-community cultures, as strains grow, and behave differently when grown in co-263 culture, compared to those grown individually [43] . Further studies, possible utilising isotope labelling, 264 would be required for targeted identification of metabolites impacting these important EPS-265 associated cross-feeding networks [44] . 266
To our knowledge, this research demonstrates for the first time, the influence of B. breve UCC2003 267 EPS on the infant microbiota using an in vitro model colon system. Although a dynamic system, with 268 media constantly replenished and waste removed, we observed short-term colonisation that 269 contributed to altered bacterial composition (i.e. abundance of Escherichia or Tyzzerella) and 270 metabolite profiles (i.e. acetate, propionate, formate or butyrate) within the EPS-positive B. breve 271 UCC2003 inoculated vessel. These combined data suggest EPS may act as a nutrient source for the 272 early life microbiota thereby driving changes in microbial community structure. Our results, in 273 combination with previously published work [22, 23] x 1 min with 5 min resting intervals on ice. Samples were centrifuged at 14,000 x g for 10 min and RNA 296 was extracted using Qiagen RNeasy mini plus kit (Qiagen) according to manufacturer's instructions. 297
The RNA quality and concentration were determined using Agilent 2100 Bioanalyzer (Agilent Inc.). 298
Only samples with RIN values above 8 were sequenced. Isolated RNA was processed with Ribo-299 depletion, and samples sequenced on HiSeq V4 75bp using nonstranded, paired end reads. 300
For computational analysis, the quality of stranded reads was assessed by FastQC software (version 301 0.11.8) [45] . Reads were aligned against the full nucleotide sequence of B. breve UCC2003 (RefSeq: 302 NC_020517). Alignment and quantification were performed using Kallisto (version 0.44.0), the 303 quantified read data was normalised and differential expression analysis was conducted using DeSeq2 304 (version 1.22.2) [46, 47] . Genes with an absolute log2 fold change ≥1 and p adj value ≤ 0.05 were 305 considered to be differentially expressed. PCA plots, heatplots and plots of differential expression 306 across the genome were generated using custom R scripts. All genes in the B. breve UCC2003 genome 307 (RefSeq: NC_020517) were functionally annotated with categories and descriptions using EggNog-308 mapper (version 4.5) [48] . Custom R scripts were used to test for enrichment of EggNog functional 309 categories in the upregulated and downregulated differentially expressed genes. This analysis was 310 carried out using gene set enrichment functions of the R package clusterProfiler (version 3.10.1) [49] . 311
All raw reads were deposited in European Nucleotide Archive: PRJEB35291. 312
Transmission electron microscopy (TEM) 313 Strains were grown as described above, and after 48h growth, cells were centrifuged at 4500 × g at 314 4°C for 10min with low break. Bacterial pellets were resuspended in 1mL of fixative comprising 2.5% 315 glutaraldehyde in 0.05M sodium cacodylate pH 7.2. Fixation was carried out for 1.5h at room 316 temperature after which, cell suspensions were centrifuged (7.5xg rpm, 3min) and washed in 0.05M 317 Sodium Cacodylate buffer x3 (10min). After final centrifugation, cell pellets were mixed 1:1 with 318 molten 2% low gelling temperature agarose, solidified by chilling, and then chopped into 1mm 3 pieces. 319
Sample pieces were post fixed in 1% OsO4 for 2h followed by washing x3 (15min) in deionised water. 320
Sample pieces were then dehydrated through an ethanol series (30%, 50%, 70%, 90%, 100% x3) for at 321 least 15min in each ethanol dilution. Samples were infiltrated with a 1:1 mix of LR White medium 322 grade resin to 100% ethanol, followed by a 2:1 and a 3:1 mix and finally 100% resin, with 1 hour 323 between each change. This was followed by two more changes into fresh 100% resin, with periods of 324 8 hours between. Four blocks/sample were put into Beem capsules (Size 00) with fresh resin and 325 polymerised for 24h at 60°C. Sections approximately 90nm thick were cut using an ultramicrotome 326 with a glass knife, collected on formvar/carbon coated 200 mesh copper grids, and stained 327 sequentially with 2% uranyl acetate for 1h at room temperature; and 0.5% lead citrate-tribasic 328 trihydrate for 1min at room temperature. Deionised water washes were performed (x5) following 329 each of the staining steps. Sections were examined and imaged in a Talos F200C transmission electron 330 microscope at 200kV with a "Gatan One View" digital Camera. 331
Infant model colon system 332
Faeces were collected from healthy, full-term breast-fed infants (aged from 7-month to 1-year old) in 333 accordance with protocols by the National Research Ethics Service (NRES) approved UEA/QIB 334 Biorepository (Licence no: 11208) and the Quadram Institute Bioscience Ethics Committee. One-gram 335 samples from five frozen stool samples were homogenized with 5mL reduced PBS (500µL of 3% L-cys 336
HCl in 50mL PBS), filtered (70m) and evenly distributed to each vessel. Model colon system media 337 was made according to Cinquin et al., and included a vitamin solution (pantothenate 10mg/L, 338 nicotinamide 5mg/L, thiamine 4mg/L, biotin 2mg/L, vitamin B12 0.5mg/L, menadione, 1mg/L and p-339 aminobenzoic acid 5mg/L) as described in Gibson and Wang [50, 51] . The continuous-fed batch 340 cultivation was performed in 1.4L bioreactors (Multifors) and monitored with Eve® software (Infors 341 AG). Parameters were set according to [50] ; briefly, vessels were maintained at 37C, pH 6.7 and 342 anaerobic, with a media exchange occurring every 12h (retention time). All vessels were given 10 days 343 to permit equilibrium of the microbiota to the in vitro vessel environment. 344
For inoculation of B. breve, strains were grown in the infant gut media. Overnight cultures were then 345 centrifuged at 4500 x g for 10 min at 4°C, washed with PBS and then inoculated into each vessel. B. 346 breve UCC2003 EPS-positive 4.4 × 10 8 CFU/vessel, and B. breve UCC2003del EPS-negative 2.4 × 10 8 347 CFU/vessel was added. Samples were snap frozen in liquid nitrogen at each time point t=0, 6, 12, 24, 348 36 hours post inoculation with B. breve, and once a day from that time point onward. 349 DNA extraction, 16S rRNA library preparation, sequencing, and bioinformatics analysis. Primer sequences for amplification are found in Table S1 . PCR amplification conditions were: 1 cycle 357 of 98°C for 2min, followed by 20 cycles of 98°C for 30s, 50°C for 30s and 72°C for 90s, and a final cycle 358 of 72°C for 5min. PCR products were purified using Ampure XP beads (Agencourt) and pooled in an 359 equivalent molar mix based on the concentration of each PCR product determined by Quant -iT™ 360 PicoGreen® dsDNA Assay Kit (Life Tech). Sequencing was performed on an Illumina MiSeq platform 361 using paired-end reads (average read length was 330bp). 16S rRNA gene sequencing analyses and 362 bioinformatics analyses were performed as previously published [25] . All raw reads were deposited in 363 European Nucleotide Archive: PRJEB35291. 364 365 1 H NMR analyses 366 50mg of model colon samples were mixed with 700L NMR buffer (0.26g NaH₂PO, 1.44gK2HPO4, 17mg 367 TSP, 56.1 mg NaN3 and 100 mL D2O) and centrifuged at 14000 xg at 4°C for 5 min. 600L of 368 supernatants were transferred into NMR tubes (GPE Scientific Ltd) and the 1 H NMR spectrum were 369 recorded at 600MHz on a Bruker Avance spectrometer (Bruker BioSpin GmbH, Rheinstetten, 370 Germany) running Topspin 3.2 software. Each 1 H NMR spectrum was acquired with 128 scans, a 371 spectral width of 12300Hz and an acquisition time of 2.7s. The "noesygppr1d" presaturation sequence 372 was used to suppress the residual water signal with a lowpower selective irradiation at the water 373 frequency during the recycle delay (3s). Spectra were transformed with a 0.3-Hz line broadening, 374 automatically phased, baseline corrected, and referenced by setting the TSP methyl signal to 0ppm. 375 13 Metabolites were identified and subsequently quantified using a library of reference standard spectra 376 provided with the Chenomx NMR suite 8.4™ software. 377
Statistical analyses and plotting 378
Statistical analyses on growth curves were performed in GraphPad Prism version 5.04. Mann-Whitney-379 U-Test was performed for cultures in MRS. Error bars denote standard deviation (SD). All plots were 380 produced using either GraphPad Prism version 5.04 or R Studio version 1. Five different stool samples from four different infants, age 6 -12 months, were combined, processed and added to each Vessel (see Methods). Vessels were allowed to acclimatise for ten days, followed by inoculation with, Vessel A: B. breve UCC2003 EPS+, and Vessel B: B. breve UCC2003del EPS-. Aseptic sampling was performed from 0-408h after inoculation and processed for 16S rRNA analyses and NMR. Samples were taken before inoculation (t=0), at time points (hours after inoculation) 6, 12, 24, 36 and from 48h to 408h every 24h. (b) NMDS plot using a Bray-Curtis dissimilarity calculation. For both vessels and separately ( Fig S2) . Changes over time are coloured from yellow (time point 0h) to red (time point 408h). 
